SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-22-258241
Filing Date
2022-10-05
Accepted
2022-10-05 16:37:03
Documents
1
Effectiveness Date
2022-10-05

Document Format Files

Seq Description Document Type Size
1 S-8 POS d375373ds8pos.htm S-8 POS 32495
  Complete submission text file 0001193125-22-258241.txt   33501
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-242336 | Film No.: 221296116
SIC: 2834 Pharmaceutical Preparations